One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(23)00045-9
Volume 21, Issue 3, March 2023, Pages A7-A9
Foaming at the Varix: Sclerotherapy of Esophageal Varices via Intrahepatic Portal Vein Access
Clara Y. Tow, 1,2 Julie Sung, 3 and Harvey Rosenberg
doi : 10.1016/j.cgh.2022.07.010
Volume 21, Issue 3, March 2023, Page A13
Intrahepatic Splenosis: Benign but Can Be Misdiagnosed
Rajanshu Verma, 1 Vamsee Mupparaju, 2 and Satheesh P. Nair
doi : 10.1016/j.cgh.2022.07.013
Volume 21, Issue 3, March 2023, Page A14
Removal of Giant Choledocholithiasis by Direct Cholangioscopy with Gastroscope and Electrohydraulic Lithotripsy
Brian M. Fung 1,2 and Teodor C. Pitea
doi : 10.1016/j.cgh.2022.07.026
Volume 21, Issue 3, March 2023, Pages A15-A16
Blue Notes
CHARLES J. KAHI, MD, MS,
doi : 10.1016/j.cgh.2022.12.019
Volume 21, Issue 3, March 2023, Pages 565-566
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion
PETER S. LIANGSIMONA C. KWONILSEUNG CHOCHAU TRINH-SHEVRINSTELLA YI
doi : 10.1016/j.cgh.2022.12.001
Volume 21, Issue 3, March 2023, Pages 567-571
How to Get Involved With Community Engagement, Community Service, and Patient Advocacy During GI Fellowship
NICOLETTE J. RODRIGUEZCANDACE HENLEYSONIA S. KUPFER
doi : 10.1016/j.cgh.2022.12.007
Volume 21, Issue 3, March 2023, Pages 572-575
Development and Implementation of a Hepatocellular Carcinoma Surveillance Quality Metric
Neehar D. Parikh, 1 Cheryl Dehmlow, 2 Tammy Ellies, 3 Elliot B. Tapper, 1 and Anna S. F. Lok 1
doi : 10.1016/j.cgh.2022.12.009
Volume 21, Issue 3, March 2023, Pages 576-580.e1
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
Giulia Martina Cavestro, 1, * Alessandro Mannucci, 1, * Francesc Balaguer, 2,3,‡ Heather Hampel, 4,‡ Sonia S. Kupfer, 5,‡ Alessandro Repici, 6,‡ Andrea Sartore-Bianchi,7,‡ Toni T. Seppälä, 8,9,10,‡ Vincenzo Valentini, 11,‡ Clement Richard Boland, 12 Randall E. Brand, 13 Tineke E. Buffart, 14 Carol A. Burke, 15 Riccardo Caccialanza, 16 Renato Cannizzaro, 17 Stefano Cascinu, 18 Andrea Cercek, 19 Emma J. Crosbie, 20,21 Silvio Danese,
doi : 0.1016/j.cgh.2022.12.006
Volume 21, Issue 3, March 2023, Pages 581-603.e33
Emerging Tests for Noninvasive Colorectal Cancer Screening
Marina Hanna, 1 Neelendu Dey, 1,2,3 and William M. Grady
doi : 10.1016/j.cgh.2022.12.008
Volume 21, Issue 3, March 2023, Pages 604-616
Colorectal cancer (CRC) is among the most common cancers globally and a major cause of cancer-related deaths. The American Cancer Society estimates that CRC will kill 1 in 60 Americans, and CRC screening is recommended for all Americans ≥45 years of age.
Can an Inspiration Around Perspiration Lead to an Innovation In IBD Management?
SAHAR TABATABAVAKILILAURA E. TARGOWNIK
doi : 10.1016/j.cgh.2022.09.027
Volume 21, Issue 3, March 2023, Pages 617-618
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
Grace En Hui Lim,*,a Ansel Tang,‡,a Cheng Han Ng,‡,a Yip Han Chin,‡ Wen Hui Lim,‡ Darren Jun Hao Tan,‡ Jie Ning Yong,‡ Jieling Xiao,‡ Chloe Wen-Min Lee,‡ Mark Chan,‡,§ Nicholas WS. Chew, § Eunice Xiang Xuan Tan,‡,jj,¶ Mohammad Shadab Siddiqui, # Daniel Huang,‡,jj,¶ Mazen Noureddin,** Arun J. Sanyal, #,b and Mark D. Muthiah
doi : 10.1016/j.cgh.2021.11.038
Volume 21, Issue 3, March 2023, Pages 619-629.e7
Risk Factors for Metachronous Colorectal Cancer or Advanced Adenomas After Endoscopic Resection of High-risk Adenomas
Sandra Baile-MaxÃa, 1 Carolina Mangas-Sanjuán, 1 Uri Ladabaum, 2 Cesare Hassan, 3,4 Matthew D. Rutter, 5,6 Michael Bretthauer, 7,8 LucÃa Medina-Prado, 1 Noelia Sala-Miquel, 1 Oscar Murcia Pomares, 1 Pedro Zapater, 9 and Rodrigo Jover
doi : 10.1016/j.cgh.2022.12.005
Volume 21, Issue 3, March 2023, Pages 630-643
Association of Standardized Radiology Reporting and Management of Abdominal CT and MRI With Diagnosis of Pancreatic Cancer
Eleanor L. Ormsby,* Kourosh Kojouri,‡ Patrick C. Chang,* Teresa Y. Lin, § Brooke Vuong,‡ Rene M. Ramirez,‡ Kristin M. Schueler,* Clifford F. Sweet,* and Lisa J. Herrinton
doi : 10.1016/j.cgh.2022.03.047
Volume 21, Issue 3, March 2023, Pages 644-652.e2
Endoscopic Surveillance for Premalignant Esophageal Lesions: A Community-Based Multicenter, Prospective Cohort Study
He Li, 1, * Shaokai Zhang, 2, * Jinyi Zhou, 3, * Feng Tong, 4, * Jiyong Gong, 4, * Zhenqiu Zha, 5, * Ni Li, 1 Changfa Xia, 1 Jiang Li, 1 Liyang Zheng, 2 Pengfei Luo, 3 Renqing Han, 3 Hengmin Ma, 4 Yili Lv, 5 Hongmei Zeng, 6 Rongshou Zheng, 6 Maomao Cao, 1 Fan Yang, 1 Xinxin Yan, 1 Dianqin Sun, 1 Siyi He,1 Shaoli Zhang, 1 Wanqing Chen, 1 and Jie He
doi : 10.1016/j.cgh.2022.04.039
Volume 21, Issue 3, March 2023, Pages 653-662.e8
Baseline Hepatitis B Virus Surface Antigen Titers in Childhood Predict the Risk of Advanced Liver Fibrosis in Adulthood
Jia-Feng Wu,* Chi-San Tai,* Kai-Chi Chang,* Huey-Ling Chen,* ,‡ Yen-Hsuan Ni,* ,‡ Hong-Yuan Hsu,* and Mei-Hwei Chang
doi : 10.1016/j.cgh.2022.02.046
Volume 21, Issue 3, March 2023, Pages 663-669.e1
Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease–Associated Hepatocellular Carcinoma in the United States
Mohammad A. Karim,* ,‡ Amit G. Singal, § Hye Chung Kum,‡ Yi-Te Lee,k Sulki Park,‡ Nicole E. Rich, § Mazen Noureddin,¶,# and Ju Dong Yang
doi : 10.1016/j.cgh.2022.03.010
Volume 21, Issue 3, March 2023, Pages 670-680.e18
Predicting the Onset of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure
Jinjin Luo,*,a Xi Liang,‡,a Jiaojiao Xin,*,a Jiaqi Li,* ,a Peng Li,* ,a Qian Zhou,* Shaorui Hao,* Huafen Zhang,* Yingyan Lu, § Tianzhou Wu,‡ Lingling Yang,k Jiang Li, ¶ Tan Li,* Keke Ren,* Beibei Guo,* Xingping Zhou,* Jiaxian Chen,* Lulu He,* Hui Yang,* Wen Hu,* Shaoli You, # Shaojie Xin, # Jing Jiang,* Dongyan Shi,* Xin Chen,** ,‡‡ and Jun Li,* for the Chinese Group on the Study of Severe Hepatitis B (COSSH)
doi : 10.1016/j.cgh.2022.03.016
Volume 21, Issue 3, March 2023, Pages 681-693
The Natural History of Advanced Chronic Liver Disease Defined by Transient Elastography
Jessica E. Shearer,*,‡ Rebecca Jones,‡ Richard Parker,‡ James Ferguson, § and Ian A. Rowe*
doi : 10.1016/j.cgh.2022.03.015
Volume 21, Issue 3, March 2023, Pages 694-703.e8
Patients With Acute-on-Chronic Liver Failure Have Greater Healthcare Resource Utilization After Liver Transplantation
Vinay Sundaram,* ,a Christina C. Lindenmeyer,‡,a Kirti Shetty, § Robert S. Rahimi,k Atef Al-Attar,* Gianina Flocco,‡ Brett E. Fortune, ¶ Cynthia Gong, # Suryanarayana Challa, § Haripriya Maddur,** Janice H. Jou,‡‡ Michael Kriss, §§ Lance L. Stein,kk Alex H. Xiao,** Ross H. Vyhmeister,‡‡ Ellen W. Green, §§ Braidie Campbell, §§ Andrew J. Piscitello, ¶¶ William Cranford,kk Josh Levitsky,‡‡,b and Constantine J. Karvellas
doi : 10.1016/j.cgh.2022.03.014
Volume 21, Issue 3, March 2023, Pages 704-712.e3
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study
Maud Lemoine,* Lambert Assoumou,‡ Pierre-Marie Girard, § Marc Antoine Valantin,k Christine Katlama,k Stephane De Wit, ¶ Pauline Campa, § Hayette Rougier, § Jean-Luc Meynard, § Coca Necsoi, ¶ Anja D. Huefner, # Jan Van Luzen,# Julian Schulze zur Wiesch,# Jean-Philippe Bastard,**,‡‡,§§,kk Soraya Fellahi,**,‡‡,kk Stefan Mauss, ¶¶ Metodi V. Stankov, ## Axel Baumgarten,*** Gerrit Post,‡‡‡ Lawrence Serfaty, §§§ Vlad Ratziu,kkk Yves Menu, ¶¶¶ Jerome Schlue, ## Pierre Bedossa,**** Jacqueline Capeau,** ,‡‡ Dominique Costagliola,‡ Georg Behrens,##,a and Patrick Ingiliz,***
doi : 10.1016/j.cgh.2022.03.048
Volume 21, Issue 3, March 2023, Pages 713-722.e3
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials
Jasmohan S. Bajaj, 1,2 Tarek I. Hassanein, 3 Nikolaos T. Pyrsopoulos, 4 Arun J. Sanyal, 1 Robert S. Rahimi, 5 Zeev Heimanson, 6 Robert J. Israel, 6 and Don C. Rockey 7
doi : 10.1016/j.cgh.2022.05.042
Volume 21, Issue 3, March 2023, Pages 723-731.e9
Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis: Results From a Prospective Multicenter Study
Mar Riveiro-Barciela, 1,2,3, * Ana Barreira-DÃaz, 1,3, * Ana Callejo-Pérez, 4 Eva Muñoz-Couselo, 4 Nely DÃaz-MejÃa, 4 Ã�lvaro DÃaz-González, 5 MarÃa-Carlota Londoño, 2,6 Maria-Teresa Salcedo, 7 and MarÃa Buti
doi : 10.1016/j.cgh.2022.03.050
Volume 21, Issue 3, March 2023, Pages 732-740
High Perceived Stress is Associated With Increased Risk of Ulcerative Colitis Clinical Flares
Jenny S. Sauk, 1,2 Hyo Jin Ryu, 1 Jennifer S. Labus, 1 Ariela Khandadash, 1 Aaron I. Ahdoot, 2 Venu Lagishetty, 2 William Katzka, 2 Hao Wang, 1 Bruce Naliboff, 1 Jonathan P. Jacobs, 1,2,3 and Emeran A. Mayer
doi : 10.1016/j.cgh.2022.07.025
Volume 21, Issue 3, March 2023, Pages 741-749.e3
Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease
Remi Mahmoud, 1, * Edo H. J. Savelkoul, 2, * Wout Mares, 3 Rogier Goetgebuer, 4,5 Ben J. M. Witteman, 3 Daan B. de Koning, 6 Sebastiaan A. C. van Tuyl, 7 Itta Minderhoud, 8 Maurice W. M. D. Lutgens, 9 Dilek Akol-Simsek, 10 Fiona D. M. van Schaik, 1 Herma H. Fidder, 1 Jeroen M. Jansen, 11 Petra G. A. van Boeckel, 12 Nofel Mahmmod, 12 Carmen S. Horjus-Talabur Horje, 13 Tessa E. H. Römkens, 14 Jean-Frédéric Colombel, 15 Frank Hoentjen, 2,16 Bindia Jharap, 17 and Bas Oldenburg
doi : 10.1016/j.cgh.2022.08.024
Volume 21, Issue 3, March 2023, Pages 750-760.e4
Inflammatory Bowel Disease Is Associated With an Increased Risk of Incident Acute Arterial Events: Analysis of the United Kingdom Biobank
Quazim A. Alayo, 1 Edward V. Loftus Jr., 2 Andres Yarur, 3 David Alvarado, 1 Matthew A. Ciorba, 1 Lisa de las Fuentes, 4,5 and Parakkal Deepak
doi : 10.1016/j.cgh.2022.08.035
Volume 21, Issue 3, March 2023, Pages 761-770.e13
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
Laurent Peyrin-Biroulet, 1 Jean-François Rahier, 2 Julien Kirchgesner, 3 Vered Abitbol, 4 Sebastian Shaji, 5 Alessandro Armuzzi, 6 Konstantinos Karmiris,7 Javier P. Gisbert, 8,9 Peter Bossuyt, 10 Ulf Helwig, 11 Johan Burisch,12,13 Henit Yanai, 14,15 Glen A. Doherty, 16 Fernando Magro, 17 Tamás Molnar, 18 Mark Löwenberg, 19 Jonas Halfvarson, 20 Edyta Zagorowicz, 21 Hélène Rousseau,22 Cédric Baumann, 22 Filip Baert, 23 and Laurent Beaugerie
doi : 10.1016/j.cgh.2022.09.018
Volume 21, Issue 3, March 2023, Pages 771-788.e10
Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study
Rithvik Golla, Sudheer Vuyyuru, Bhaskar Kante, Peeyush Kumar, David Mathew Thomas, Govind Makharia, Saurabh Kedia, and Vineet Ahuja
doi : 10.1016/j.cgh.2022.10.015
Volume 21, Issue 3, March 2023, Pages 789-796.e1
Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer
Myrtle F. Krul, 1 Marloes A. G. Elferink, 2 Niels F. M. Kok, 1 Evelien Dekker, 3 Iris Lansdorp-Vogelaar, 4 Gerrit A. Meijer, 5 Iris D. Nagtegaal, 6 Emilie C. H. Breekveldt, 4,7 Theo J. M. Ruers, 1 Monique E. van Leerdam, 7,8 and Koert F. D. Kuhlmann
doi : 10.1016/j.cgh.2022.08.046
Volume 21, Issue 3, March 2023, Pages 797-807.e3
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C)
Hongda Chen, 1, * Jufang Shi, 2, * Ming Lu, 1 Yanjie Li,2 Lingbin Du, MPH, 3 Xianzhen Liao, 4 Donghua Wei, 5 Dong Dong, 6 Yi Gao, 7 Chen Zhu, 3 Rongbiao Ying, 8 Weifang Zheng, 9 Shipeng Yan, 4 Haifan Xiao, 4 Juan Zhang, 5 Yunxin Kong, 6 Furong Li, 7 Shuangmei Zou, 10 Chengcheng Liu, 11 Hong Wang, 12 Yuhan Zhang, 1 Bin Lu, 1 Chenyu Luo, 1 Jie Cai, 13 Jianbo Tian, 14 Xiaoping Miao, 14 Kefeng Ding, 11,15 Hermann Brenner, 16,17,18 and Min Dai
doi : 10.1016/j.cgh.2022.08.003
Volume 21, Issue 3, March 2023, Pages 808-818
Risk-Adapted Starting Age for Personalized Colorectal Cancer Screening: Validated Evidence From National Population-Based Studies
Xuesi Dong, 1,2, * Zilin Luo, 1,2, * Zheng Wu, 1,2 Dong Hang, 3 Changfa Xia, 1,2 Fei Wang, 1,2 Yadi Zheng, 1,2 Yiwen Yu, 1,2 Yongjie Xu, 1,2 Wei Cao, 1,2 Chao Qin, 1,2 Liang Zhao, 1,2 Jiang Li,1,2 Jiansong Ren, 1,2 Jufang Shi, 1,2 Mulong Du,3 Wanqing Chen, 1,2 Hongbing Shen, 3 Ni Li, 1,2 Jie He
doi : 10.1016/j.cgh.2022.11.005
Volume 21, Issue 3, March 2023, Pages 819-826.e13
Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50
TIMOTHY YENJACK SCOLAROERIC MONTMINYJORDAN J. KARLITZSACHIN WANISWATI G. PATEL
doi : 10.1016/j.cgh.2021.11.017
Volume 21, Issue 3, March 2023, Pages 827-829.e3
Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis
AMIT G. SINGALSAURABH P. NAGARABBY HITCHENSKEITH L. DAVIS, MASHRIVIDYA IYER
doi : 10.1016/j.cgh.2021.11.020
Volume 21, Issue 3, March 2023, Pages 830-831.e1
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial
WILLIAM D. CHEYJASON R. BAKERLYDIA WATTSADRIENNE HARRISERIC D. SHAH
doi : 10.1016/j.cgh.2021.11.034
Volume 21, Issue 3, March 2023, Pages 832-834
An Evaluation of Online Cirrhosis-related Information Intended for Patients and Caregivers
development. It also raises the potential opportunity forKATHLEEN P. ISMONDETHAN LOCH-ISMONDPUNEETA TANDONJUDE SPIERS
doi : 10.1016/j.cgh.2022.02.024
Volume 21, Issue 3, March 2023, Pages 835-837.e8
Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn’s Disease
NATHALIE VAN DEN BERGHEBRAM VERSTOCKTSÉVERINE VERMEIREDEBBY THOMASPAUL DECLERCK
doi : 10.1016/j.cgh.2021.12.020
Volume 21, Issue 3, March 2023, Pages 838-840.e2
Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study
JANA G. HASHASHAAKASH DESAIGURSIMRAN S. KOCHHARFRANCIS A. FARRAYE
doi : 10.1016/j.cgh.2022.09.011
Volume 21, Issue 3, March 2023, Pages 841-843.e4
Novel Diagnostic Autoantibodies Against Endothelial Protein C Receptor in Patients With Ulcerative Colitis
YOICHI KAKUTA, MD, PhDTSUYOSHI SHIRAI, MD, PhDDERMOT P.B. MCGOVERN, MD, FRCP, PhDJONATHAN BRAUN, MD, PhDHIROSHI FUJII, MD, PhDATSUSHI MASAMUNE, MD, PhD
doi : 10.1016/j.cgh.2021.12.035
Volume 21, Issue 3, March 2023, Pages 844-846
Can a Defecation Posture Modifying Device Correct an Abnormal Balloon Expulsion Test in Chronically Constipated Patients?
EDEN KOOWILLIAM D. CHEYGABRIELLE EZELLJASON R. BAKERMOIRA ARMSTRONGBORKO NOJKOV
doi : 10.1016/j.cgh.2021.12.048
Volume 21, Issue 3, March 2023, Pages 847-848.e2
Exam 1: Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
doi : 10.1016/j.cgh.2022.12.020
Volume 21, Issue 3, March 2023, Pages e7-e10
Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?
LAURENS A. VAN KLEEF, MDIBRAHIM AYADA, MDROBERT J. DE KNEGT, PhD
doi : 10.1016/j.cgh.2022.04.003
Volume 21, Issue 3, March 2023, Page 849
Reply
ANSEL SHAO PIN TANG, MBBS (S’PORE) CHENG HAN NG, MBBS (S’PORE)MARK D. MUTHIAH, MBBS (S’PORE)
doi : 10.1016/j.cgh.2022.05.024
Volume 21, Issue 3, March 2023, Pages 849-850
Confirming Effectiveness of Endoscopic Colon Cancer Screening in Inflammatory Bowel Disease: The Puzzle Remains Unsolved?
MAARTEN TE GROEN, MDFRANK HOENTJEN, MD, PhD
doi : 10.1016/j.cgh.2022.04.002
Volume 21, Issue 3, March 2023, Pages 850-851
Reply
HYUNSEOK KIM, MD, MPH, PHDJASON K. HOU, MD, MS
doi : 10.1016/j.cgh.2022.05.049
Volume 21, Issue 3, March 2023, Pages 851-852
Linked Color Imaging for the Detection of Colorectal Sessile Serrated Lesions
XIU-HE LV, MDQING LU, MDJIN-LIN YANG, MD
doi : 10.1016/j.cgh.2022.04.029
Volume 21, Issue 3, March 2023, Page 852
Reply
JUN LI, MMFENG LIU, MD
doi : 10.1016/j.cgh.2022.05.050
Volume 21, Issue 3, March 2023, Pages 852-853
Cold Snare Polypectomy for Large Sessile Polyp: Is it Really Ready?
of adenocarcinoma, but that is not the case. It has beenYUICHI SHIMODATE, MDHIROKAZU MOURI, MD, PhDMOTOWO MIZUNO, MD, PhD
doi : 10.1016/j.cgh.2022.04.020
Volume 21, Issue 3, March 2023, Pages 853-854
Reply
XIANZONG MA, MMLANG YANG, MD, PhDJOSEPH LEUNG, MDJIANQIU SHENG, MD, PhDYUQI HE, MD, PhD
doi : 10.1016/j.cgh.2022.05.052
Volume 21, Issue 3, March 2023, Pages 854-855
Sex-separated NAFLD/NASH Scores May Improve Predictive Performance
SEOGSONG JEONG, MD, PhDHYE JUN KIM, BAHYUN WOOK HAN, MD, PhD
doi : 10.1016/j.cgh.2022.04.041
Volume 21, Issue 3, March 2023, Pages 855-856
Reply
FEDERICA TAVAGLIONE, MDANTONIO DE VINCENTIS, MD, PhDOVEIS JAMIALAHMADI, PhDUMBERTO VESPASIANI-GENTILUCCI, MD, PhDSTEFANO ROMEO, MD, PhD
doi : 10.1016/j.cgh.2022.06.008
Volume 21, Issue 3, March 2023, Pages 856-857
Metabolically Healthy Obese MAFLD: Are They Truly Healthy?
YASSER FOUAD, MDMING-HUA ZHENG, MD, PhD
doi : 10.1016/j.cgh.2022.05.010
Volume 21, Issue 3, March 2023, Pages 857-858
Reply
EILEEN L. YOON, MD, PhDHUIYUL PARK, MD, PhDDAE WON JUN, MD, PhD
doi : 10.1016/j.cgh.2022.06.009
Volume 21, Issue 3, March 2023, Pages 858-859
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(23)00045-9
Volume 21, Issue 3, March 2023, Pages A7-A9
Foaming at the Varix: Sclerotherapy of Esophageal Varices via Intrahepatic Portal Vein Access
Clara Y. Tow, 1,2 Julie Sung, 3 and Harvey Rosenberg
doi : 10.1016/j.cgh.2022.07.010
Volume 21, Issue 3, March 2023, Page A13
Intrahepatic Splenosis: Benign but Can Be Misdiagnosed
Rajanshu Verma, 1 Vamsee Mupparaju, 2 and Satheesh P. Nair
doi : 10.1016/j.cgh.2022.07.013
Volume 21, Issue 3, March 2023, Page A14
Removal of Giant Choledocholithiasis by Direct Cholangioscopy with Gastroscope and Electrohydraulic Lithotripsy
Brian M. Fung 1,2 and Teodor C. Pitea
doi : 10.1016/j.cgh.2022.07.026
Volume 21, Issue 3, March 2023, Pages A15-A16
Blue Notes
CHARLES J. KAHI, MD, MS,
doi : 10.1016/j.cgh.2022.12.019
Volume 21, Issue 3, March 2023, Pages 565-566
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion
PETER S. LIANGSIMONA C. KWONILSEUNG CHOCHAU TRINH-SHEVRINSTELLA YI
doi : 10.1016/j.cgh.2022.12.001
Volume 21, Issue 3, March 2023, Pages 567-571
How to Get Involved With Community Engagement, Community Service, and Patient Advocacy During GI Fellowship
NICOLETTE J. RODRIGUEZCANDACE HENLEYSONIA S. KUPFER
doi : 10.1016/j.cgh.2022.12.007
Volume 21, Issue 3, March 2023, Pages 572-575
Development and Implementation of a Hepatocellular Carcinoma Surveillance Quality Metric
Neehar D. Parikh, 1 Cheryl Dehmlow, 2 Tammy Ellies, 3 Elliot B. Tapper, 1 and Anna S. F. Lok 1
doi : 10.1016/j.cgh.2022.12.009
Volume 21, Issue 3, March 2023, Pages 576-580.e1
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
Giulia Martina Cavestro, 1, * Alessandro Mannucci, 1, * Francesc Balaguer, 2,3,‡ Heather Hampel, 4,‡ Sonia S. Kupfer, 5,‡ Alessandro Repici, 6,‡ Andrea Sartore-Bianchi,7,‡ Toni T. Seppälä, 8,9,10,‡ Vincenzo Valentini, 11,‡ Clement Richard Boland, 12 Randall E. Brand, 13 Tineke E. Buffart, 14 Carol A. Burke, 15 Riccardo Caccialanza, 16 Renato Cannizzaro, 17 Stefano Cascinu, 18 Andrea Cercek, 19 Emma J. Crosbie, 20,21 Silvio Danese,
doi : 0.1016/j.cgh.2022.12.006
Volume 21, Issue 3, March 2023, Pages 581-603.e33
Emerging Tests for Noninvasive Colorectal Cancer Screening
Marina Hanna, 1 Neelendu Dey, 1,2,3 and William M. Grady
doi : 10.1016/j.cgh.2022.12.008
Volume 21, Issue 3, March 2023, Pages 604-616
Colorectal cancer (CRC) is among the most common cancers globally and a major cause of cancer-related deaths. The American Cancer Society estimates that CRC will kill 1 in 60 Americans, and CRC screening is recommended for all Americans ≥45 years of age.
Can an Inspiration Around Perspiration Lead to an Innovation In IBD Management?
SAHAR TABATABAVAKILILAURA E. TARGOWNIK
doi : 10.1016/j.cgh.2022.09.027
Volume 21, Issue 3, March 2023, Pages 617-618
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
Grace En Hui Lim,*,a Ansel Tang,‡,a Cheng Han Ng,‡,a Yip Han Chin,‡ Wen Hui Lim,‡ Darren Jun Hao Tan,‡ Jie Ning Yong,‡ Jieling Xiao,‡ Chloe Wen-Min Lee,‡ Mark Chan,‡,§ Nicholas WS. Chew, § Eunice Xiang Xuan Tan,‡,jj,¶ Mohammad Shadab Siddiqui, # Daniel Huang,‡,jj,¶ Mazen Noureddin,** Arun J. Sanyal, #,b and Mark D. Muthiah
doi : 10.1016/j.cgh.2021.11.038
Volume 21, Issue 3, March 2023, Pages 619-629.e7
Risk Factors for Metachronous Colorectal Cancer or Advanced Adenomas After Endoscopic Resection of High-risk Adenomas
Sandra Baile-MaxÃa, 1 Carolina Mangas-Sanjuán, 1 Uri Ladabaum, 2 Cesare Hassan, 3,4 Matthew D. Rutter, 5,6 Michael Bretthauer, 7,8 LucÃa Medina-Prado, 1 Noelia Sala-Miquel, 1 Oscar Murcia Pomares, 1 Pedro Zapater, 9 and Rodrigo Jover
doi : 10.1016/j.cgh.2022.12.005
Volume 21, Issue 3, March 2023, Pages 630-643
Association of Standardized Radiology Reporting and Management of Abdominal CT and MRI With Diagnosis of Pancreatic Cancer
Eleanor L. Ormsby,* Kourosh Kojouri,‡ Patrick C. Chang,* Teresa Y. Lin, § Brooke Vuong,‡ Rene M. Ramirez,‡ Kristin M. Schueler,* Clifford F. Sweet,* and Lisa J. Herrinton
doi : 10.1016/j.cgh.2022.03.047
Volume 21, Issue 3, March 2023, Pages 644-652.e2
Endoscopic Surveillance for Premalignant Esophageal Lesions: A Community-Based Multicenter, Prospective Cohort Study
He Li, 1, * Shaokai Zhang, 2, * Jinyi Zhou, 3, * Feng Tong, 4, * Jiyong Gong, 4, * Zhenqiu Zha, 5, * Ni Li, 1 Changfa Xia, 1 Jiang Li, 1 Liyang Zheng, 2 Pengfei Luo, 3 Renqing Han, 3 Hengmin Ma, 4 Yili Lv, 5 Hongmei Zeng, 6 Rongshou Zheng, 6 Maomao Cao, 1 Fan Yang, 1 Xinxin Yan, 1 Dianqin Sun, 1 Siyi He,1 Shaoli Zhang, 1 Wanqing Chen, 1 and Jie He
doi : 10.1016/j.cgh.2022.04.039
Volume 21, Issue 3, March 2023, Pages 653-662.e8
Baseline Hepatitis B Virus Surface Antigen Titers in Childhood Predict the Risk of Advanced Liver Fibrosis in Adulthood
Jia-Feng Wu,* Chi-San Tai,* Kai-Chi Chang,* Huey-Ling Chen,* ,‡ Yen-Hsuan Ni,* ,‡ Hong-Yuan Hsu,* and Mei-Hwei Chang
doi : 10.1016/j.cgh.2022.02.046
Volume 21, Issue 3, March 2023, Pages 663-669.e1
Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease–Associated Hepatocellular Carcinoma in the United States
Mohammad A. Karim,* ,‡ Amit G. Singal, § Hye Chung Kum,‡ Yi-Te Lee,k Sulki Park,‡ Nicole E. Rich, § Mazen Noureddin,¶,# and Ju Dong Yang
doi : 10.1016/j.cgh.2022.03.010
Volume 21, Issue 3, March 2023, Pages 670-680.e18
Predicting the Onset of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure
Jinjin Luo,*,a Xi Liang,‡,a Jiaojiao Xin,*,a Jiaqi Li,* ,a Peng Li,* ,a Qian Zhou,* Shaorui Hao,* Huafen Zhang,* Yingyan Lu, § Tianzhou Wu,‡ Lingling Yang,k Jiang Li, ¶ Tan Li,* Keke Ren,* Beibei Guo,* Xingping Zhou,* Jiaxian Chen,* Lulu He,* Hui Yang,* Wen Hu,* Shaoli You, # Shaojie Xin, # Jing Jiang,* Dongyan Shi,* Xin Chen,** ,‡‡ and Jun Li,* for the Chinese Group on the Study of Severe Hepatitis B (COSSH)
doi : 10.1016/j.cgh.2022.03.016
Volume 21, Issue 3, March 2023, Pages 681-693
The Natural History of Advanced Chronic Liver Disease Defined by Transient Elastography
Jessica E. Shearer,*,‡ Rebecca Jones,‡ Richard Parker,‡ James Ferguson, § and Ian A. Rowe*
doi : 10.1016/j.cgh.2022.03.015
Volume 21, Issue 3, March 2023, Pages 694-703.e8
Patients With Acute-on-Chronic Liver Failure Have Greater Healthcare Resource Utilization After Liver Transplantation
Vinay Sundaram,* ,a Christina C. Lindenmeyer,‡,a Kirti Shetty, § Robert S. Rahimi,k Atef Al-Attar,* Gianina Flocco,‡ Brett E. Fortune, ¶ Cynthia Gong, # Suryanarayana Challa, § Haripriya Maddur,** Janice H. Jou,‡‡ Michael Kriss, §§ Lance L. Stein,kk Alex H. Xiao,** Ross H. Vyhmeister,‡‡ Ellen W. Green, §§ Braidie Campbell, §§ Andrew J. Piscitello, ¶¶ William Cranford,kk Josh Levitsky,‡‡,b and Constantine J. Karvellas
doi : 10.1016/j.cgh.2022.03.014
Volume 21, Issue 3, March 2023, Pages 704-712.e3
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study
Maud Lemoine,* Lambert Assoumou,‡ Pierre-Marie Girard, § Marc Antoine Valantin,k Christine Katlama,k Stephane De Wit, ¶ Pauline Campa, § Hayette Rougier, § Jean-Luc Meynard, § Coca Necsoi, ¶ Anja D. Huefner, # Jan Van Luzen,# Julian Schulze zur Wiesch,# Jean-Philippe Bastard,**,‡‡,§§,kk Soraya Fellahi,**,‡‡,kk Stefan Mauss, ¶¶ Metodi V. Stankov, ## Axel Baumgarten,*** Gerrit Post,‡‡‡ Lawrence Serfaty, §§§ Vlad Ratziu,kkk Yves Menu, ¶¶¶ Jerome Schlue, ## Pierre Bedossa,**** Jacqueline Capeau,** ,‡‡ Dominique Costagliola,‡ Georg Behrens,##,a and Patrick Ingiliz,***
doi : 10.1016/j.cgh.2022.03.048
Volume 21, Issue 3, March 2023, Pages 713-722.e3
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials
Jasmohan S. Bajaj, 1,2 Tarek I. Hassanein, 3 Nikolaos T. Pyrsopoulos, 4 Arun J. Sanyal, 1 Robert S. Rahimi, 5 Zeev Heimanson, 6 Robert J. Israel, 6 and Don C. Rockey 7
doi : 10.1016/j.cgh.2022.05.042
Volume 21, Issue 3, March 2023, Pages 723-731.e9
Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis: Results From a Prospective Multicenter Study
Mar Riveiro-Barciela, 1,2,3, * Ana Barreira-DÃaz, 1,3, * Ana Callejo-Pérez, 4 Eva Muñoz-Couselo, 4 Nely DÃaz-MejÃa, 4 Ã�lvaro DÃaz-González, 5 MarÃa-Carlota Londoño, 2,6 Maria-Teresa Salcedo, 7 and MarÃa Buti
doi : 10.1016/j.cgh.2022.03.050
Volume 21, Issue 3, March 2023, Pages 732-740
High Perceived Stress is Associated With Increased Risk of Ulcerative Colitis Clinical Flares
Jenny S. Sauk, 1,2 Hyo Jin Ryu, 1 Jennifer S. Labus, 1 Ariela Khandadash, 1 Aaron I. Ahdoot, 2 Venu Lagishetty, 2 William Katzka, 2 Hao Wang, 1 Bruce Naliboff, 1 Jonathan P. Jacobs, 1,2,3 and Emeran A. Mayer
doi : 10.1016/j.cgh.2022.07.025
Volume 21, Issue 3, March 2023, Pages 741-749.e3
Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease
Remi Mahmoud, 1, * Edo H. J. Savelkoul, 2, * Wout Mares, 3 Rogier Goetgebuer, 4,5 Ben J. M. Witteman, 3 Daan B. de Koning, 6 Sebastiaan A. C. van Tuyl, 7 Itta Minderhoud, 8 Maurice W. M. D. Lutgens, 9 Dilek Akol-Simsek, 10 Fiona D. M. van Schaik, 1 Herma H. Fidder, 1 Jeroen M. Jansen, 11 Petra G. A. van Boeckel, 12 Nofel Mahmmod, 12 Carmen S. Horjus-Talabur Horje, 13 Tessa E. H. Römkens, 14 Jean-Frédéric Colombel, 15 Frank Hoentjen, 2,16 Bindia Jharap, 17 and Bas Oldenburg
doi : 10.1016/j.cgh.2022.08.024
Volume 21, Issue 3, March 2023, Pages 750-760.e4
Inflammatory Bowel Disease Is Associated With an Increased Risk of Incident Acute Arterial Events: Analysis of the United Kingdom Biobank
Quazim A. Alayo, 1 Edward V. Loftus Jr., 2 Andres Yarur, 3 David Alvarado, 1 Matthew A. Ciorba, 1 Lisa de las Fuentes, 4,5 and Parakkal Deepak
doi : 10.1016/j.cgh.2022.08.035
Volume 21, Issue 3, March 2023, Pages 761-770.e13
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
Laurent Peyrin-Biroulet, 1 Jean-François Rahier, 2 Julien Kirchgesner, 3 Vered Abitbol, 4 Sebastian Shaji, 5 Alessandro Armuzzi, 6 Konstantinos Karmiris,7 Javier P. Gisbert, 8,9 Peter Bossuyt, 10 Ulf Helwig, 11 Johan Burisch,12,13 Henit Yanai, 14,15 Glen A. Doherty, 16 Fernando Magro, 17 Tamás Molnar, 18 Mark Löwenberg, 19 Jonas Halfvarson, 20 Edyta Zagorowicz, 21 Hélène Rousseau,22 Cédric Baumann, 22 Filip Baert, 23 and Laurent Beaugerie
doi : 10.1016/j.cgh.2022.09.018
Volume 21, Issue 3, March 2023, Pages 771-788.e10
Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study
Rithvik Golla, Sudheer Vuyyuru, Bhaskar Kante, Peeyush Kumar, David Mathew Thomas, Govind Makharia, Saurabh Kedia, and Vineet Ahuja
doi : 10.1016/j.cgh.2022.10.015
Volume 21, Issue 3, March 2023, Pages 789-796.e1
Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer
Myrtle F. Krul, 1 Marloes A. G. Elferink, 2 Niels F. M. Kok, 1 Evelien Dekker, 3 Iris Lansdorp-Vogelaar, 4 Gerrit A. Meijer, 5 Iris D. Nagtegaal, 6 Emilie C. H. Breekveldt, 4,7 Theo J. M. Ruers, 1 Monique E. van Leerdam, 7,8 and Koert F. D. Kuhlmann
doi : 10.1016/j.cgh.2022.08.046
Volume 21, Issue 3, March 2023, Pages 797-807.e3
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C)
Hongda Chen, 1, * Jufang Shi, 2, * Ming Lu, 1 Yanjie Li,2 Lingbin Du, MPH, 3 Xianzhen Liao, 4 Donghua Wei, 5 Dong Dong, 6 Yi Gao, 7 Chen Zhu, 3 Rongbiao Ying, 8 Weifang Zheng, 9 Shipeng Yan, 4 Haifan Xiao, 4 Juan Zhang, 5 Yunxin Kong, 6 Furong Li, 7 Shuangmei Zou, 10 Chengcheng Liu, 11 Hong Wang, 12 Yuhan Zhang, 1 Bin Lu, 1 Chenyu Luo, 1 Jie Cai, 13 Jianbo Tian, 14 Xiaoping Miao, 14 Kefeng Ding, 11,15 Hermann Brenner, 16,17,18 and Min Dai
doi : 10.1016/j.cgh.2022.08.003
Volume 21, Issue 3, March 2023, Pages 808-818
Risk-Adapted Starting Age for Personalized Colorectal Cancer Screening: Validated Evidence From National Population-Based Studies
Xuesi Dong, 1,2, * Zilin Luo, 1,2, * Zheng Wu, 1,2 Dong Hang, 3 Changfa Xia, 1,2 Fei Wang, 1,2 Yadi Zheng, 1,2 Yiwen Yu, 1,2 Yongjie Xu, 1,2 Wei Cao, 1,2 Chao Qin, 1,2 Liang Zhao, 1,2 Jiang Li,1,2 Jiansong Ren, 1,2 Jufang Shi, 1,2 Mulong Du,3 Wanqing Chen, 1,2 Hongbing Shen, 3 Ni Li, 1,2 Jie He
doi : 10.1016/j.cgh.2022.11.005
Volume 21, Issue 3, March 2023, Pages 819-826.e13
Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50
TIMOTHY YENJACK SCOLAROERIC MONTMINYJORDAN J. KARLITZSACHIN WANISWATI G. PATEL
doi : 10.1016/j.cgh.2021.11.017
Volume 21, Issue 3, March 2023, Pages 827-829.e3
Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis
AMIT G. SINGALSAURABH P. NAGARABBY HITCHENSKEITH L. DAVIS, MASHRIVIDYA IYER
doi : 10.1016/j.cgh.2021.11.020
Volume 21, Issue 3, March 2023, Pages 830-831.e1
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial
WILLIAM D. CHEYJASON R. BAKERLYDIA WATTSADRIENNE HARRISERIC D. SHAH
doi : 10.1016/j.cgh.2021.11.034
Volume 21, Issue 3, March 2023, Pages 832-834
An Evaluation of Online Cirrhosis-related Information Intended for Patients and Caregivers
development. It also raises the potential opportunity forKATHLEEN P. ISMONDETHAN LOCH-ISMONDPUNEETA TANDONJUDE SPIERS
doi : 10.1016/j.cgh.2022.02.024
Volume 21, Issue 3, March 2023, Pages 835-837.e8
Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn’s Disease
NATHALIE VAN DEN BERGHEBRAM VERSTOCKTSÉVERINE VERMEIREDEBBY THOMASPAUL DECLERCK
doi : 10.1016/j.cgh.2021.12.020
Volume 21, Issue 3, March 2023, Pages 838-840.e2
Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study
JANA G. HASHASHAAKASH DESAIGURSIMRAN S. KOCHHARFRANCIS A. FARRAYE
doi : 10.1016/j.cgh.2022.09.011
Volume 21, Issue 3, March 2023, Pages 841-843.e4
Novel Diagnostic Autoantibodies Against Endothelial Protein C Receptor in Patients With Ulcerative Colitis
YOICHI KAKUTA, MD, PhDTSUYOSHI SHIRAI, MD, PhDDERMOT P.B. MCGOVERN, MD, FRCP, PhDJONATHAN BRAUN, MD, PhDHIROSHI FUJII, MD, PhDATSUSHI MASAMUNE, MD, PhD
doi : 10.1016/j.cgh.2021.12.035
Volume 21, Issue 3, March 2023, Pages 844-846
Can a Defecation Posture Modifying Device Correct an Abnormal Balloon Expulsion Test in Chronically Constipated Patients?
EDEN KOOWILLIAM D. CHEYGABRIELLE EZELLJASON R. BAKERMOIRA ARMSTRONGBORKO NOJKOV
doi : 10.1016/j.cgh.2021.12.048
Volume 21, Issue 3, March 2023, Pages 847-848.e2
Exam 1: Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
doi : 10.1016/j.cgh.2022.12.020
Volume 21, Issue 3, March 2023, Pages e7-e10
Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?
LAURENS A. VAN KLEEF, MDIBRAHIM AYADA, MDROBERT J. DE KNEGT, PhD
doi : 10.1016/j.cgh.2022.04.003
Volume 21, Issue 3, March 2023, Page 849
Reply
ANSEL SHAO PIN TANG, MBBS (S’PORE) CHENG HAN NG, MBBS (S’PORE)MARK D. MUTHIAH, MBBS (S’PORE)
doi : 10.1016/j.cgh.2022.05.024
Volume 21, Issue 3, March 2023, Pages 849-850
Confirming Effectiveness of Endoscopic Colon Cancer Screening in Inflammatory Bowel Disease: The Puzzle Remains Unsolved?
MAARTEN TE GROEN, MDFRANK HOENTJEN, MD, PhD
doi : 10.1016/j.cgh.2022.04.002
Volume 21, Issue 3, March 2023, Pages 850-851
Reply
HYUNSEOK KIM, MD, MPH, PHDJASON K. HOU, MD, MS
doi : 10.1016/j.cgh.2022.05.049
Volume 21, Issue 3, March 2023, Pages 851-852
Linked Color Imaging for the Detection of Colorectal Sessile Serrated Lesions
XIU-HE LV, MDQING LU, MDJIN-LIN YANG, MD
doi : 10.1016/j.cgh.2022.04.029
Volume 21, Issue 3, March 2023, Page 852
Reply
JUN LI, MMFENG LIU, MD
doi : 10.1016/j.cgh.2022.05.050
Volume 21, Issue 3, March 2023, Pages 852-853
Cold Snare Polypectomy for Large Sessile Polyp: Is it Really Ready?
of adenocarcinoma, but that is not the case. It has beenYUICHI SHIMODATE, MDHIROKAZU MOURI, MD, PhDMOTOWO MIZUNO, MD, PhD
doi : 10.1016/j.cgh.2022.04.020
Volume 21, Issue 3, March 2023, Pages 853-854
Reply
XIANZONG MA, MMLANG YANG, MD, PhDJOSEPH LEUNG, MDJIANQIU SHENG, MD, PhDYUQI HE, MD, PhD
doi : 10.1016/j.cgh.2022.05.052
Volume 21, Issue 3, March 2023, Pages 854-855
Sex-separated NAFLD/NASH Scores May Improve Predictive Performance
SEOGSONG JEONG, MD, PhDHYE JUN KIM, BAHYUN WOOK HAN, MD, PhD
doi : 10.1016/j.cgh.2022.04.041
Volume 21, Issue 3, March 2023, Pages 855-856
Reply
FEDERICA TAVAGLIONE, MDANTONIO DE VINCENTIS, MD, PhDOVEIS JAMIALAHMADI, PhDUMBERTO VESPASIANI-GENTILUCCI, MD, PhDSTEFANO ROMEO, MD, PhD
doi : 10.1016/j.cgh.2022.06.008
Volume 21, Issue 3, March 2023, Pages 856-857
Metabolically Healthy Obese MAFLD: Are They Truly Healthy?
YASSER FOUAD, MDMING-HUA ZHENG, MD, PhD
doi : 10.1016/j.cgh.2022.05.010
Volume 21, Issue 3, March 2023, Pages 857-858
Reply
EILEEN L. YOON, MD, PhDHUIYUL PARK, MD, PhDDAE WON JUN, MD, PhD
doi : 10.1016/j.cgh.2022.06.009
Volume 21, Issue 3, March 2023, Pages 858-859
